ZULIAN, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 7.793
AS - Asia 3.417
EU - Europa 2.205
AF - Africa 1.073
SA - Sud America 795
OC - Oceania 105
Continente sconosciuto - Info sul continente non disponibili 46
Totale 15.434
Nazione #
US - Stati Uniti d'America 7.239
SG - Singapore 1.011
CN - Cina 548
HK - Hong Kong 529
BR - Brasile 467
DE - Germania 276
IT - Italia 245
VN - Vietnam 210
FI - Finlandia 206
PL - Polonia 199
RU - Federazione Russa 123
FR - Francia 79
IN - India 76
SE - Svezia 72
GB - Regno Unito 67
NL - Olanda 66
UA - Ucraina 64
KR - Corea 62
AR - Argentina 59
TR - Turchia 51
MX - Messico 49
AT - Austria 47
CR - Costa Rica 45
IE - Irlanda 45
AE - Emirati Arabi Uniti 44
PA - Panama 41
ZA - Sudafrica 40
JO - Giordania 39
CI - Costa d'Avorio 38
CL - Cile 38
CZ - Repubblica Ceca 38
ES - Italia 38
RE - Reunion 38
BF - Burkina Faso 37
MG - Madagascar 37
UG - Uganda 37
ID - Indonesia 36
IQ - Iraq 36
KG - Kirghizistan 36
SA - Arabia Saudita 36
AZ - Azerbaigian 35
CO - Colombia 35
DZ - Algeria 35
EC - Ecuador 35
TH - Thailandia 35
AM - Armenia 34
CY - Cipro 34
HU - Ungheria 34
KE - Kenya 34
MY - Malesia 34
JM - Giamaica 33
JP - Giappone 33
PH - Filippine 33
GN - Guinea 32
PE - Perù 32
PT - Portogallo 32
YT - Mayotte 32
AL - Albania 31
GH - Ghana 31
GR - Grecia 31
NE - Niger 31
NI - Nicaragua 31
VE - Venezuela 31
BG - Bulgaria 30
HR - Croazia 30
IR - Iran 30
LA - Repubblica Popolare Democratica del Laos 30
PK - Pakistan 30
AO - Angola 29
EG - Egitto 29
ML - Mali 29
PS - Palestinian Territory 29
RS - Serbia 29
BB - Barbados 28
LB - Libano 28
NP - Nepal 28
SO - Somalia 28
ZM - Zambia 28
AD - Andorra 27
BY - Bielorussia 27
CH - Svizzera 27
CU - Cuba 27
DK - Danimarca 27
IL - Israele 27
MN - Mongolia 27
PY - Paraguay 27
TJ - Tagikistan 27
UY - Uruguay 27
BE - Belgio 26
CA - Canada 26
CV - Capo Verde 26
LU - Lussemburgo 26
LY - Libia 26
MD - Moldavia 26
ME - Montenegro 26
SI - Slovenia 26
TW - Taiwan 26
XK - ???statistics.table.value.countryCode.XK??? 26
YE - Yemen 26
ZW - Zimbabwe 26
Totale 14.219
Città #
Fairfield 1.287
Ashburn 681
Singapore 641
Woodbridge 597
Houston 558
Hong Kong 505
Cambridge 438
Seattle 429
Wilmington 395
Chandler 284
Ann Arbor 282
Santa Clara 192
Beijing 173
Boardman 173
Bytom 169
Jacksonville 162
Princeton 158
Munich 156
San Diego 138
Helsinki 133
Medford 122
Des Moines 89
Dong Ket 66
Los Angeles 66
Ho Chi Minh City 49
Roxbury 49
Chicago 47
Nanjing 46
São Paulo 44
Hefei 43
Panama City 40
Padova 39
Amman 38
Dublin 36
Abidjan 35
Kampala 35
San José 35
Hanoi 34
Vienna 34
Antananarivo 32
Seoul 32
Baku 31
Conakry 31
Managua 31
Ouagadougou 30
Nairobi 29
London 28
Lusaka 28
Accra 27
Bishkek 27
Ulan Bator 27
Yerevan 27
Andorra la Vella 26
Bamako 26
Bridgetown 26
Dushanbe 26
Vientiane 26
Luanda 25
Montevideo 25
Nuremberg 25
Castries 24
Dakar 24
Harare 24
Jinan 24
Niamey 24
Nouakchott 24
Podgorica 24
Salt Lake City 24
Turku 24
Mamoudzou 23
New York 23
Phnom Penh 23
Djibouti 22
Pristina 22
Riga 22
Tashkent 22
Havana 21
Hebei 21
Noumea 21
Praia 21
Reykjavik 21
Sofia 21
Johannesburg 20
Kingston 20
Nanchang 20
Kigali 19
Libreville 19
Nassau 19
Tallinn 19
Tirana 19
Willemstad 19
Zagreb 19
Buffalo 18
Dar es Salaam 18
Dubai 18
Gaborone 18
Guayaquil 18
Kuala Lumpur 18
Nicosia 18
Budapest 17
Totale 9.918
Nome #
Case report: Exploring under the tip of the iceberg: A case series of "self-limiting" multisystem inflammatory syndrome in children 255
A new computerized method for the assessment of skin lesions in Localized Scleroderma 200
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative 192
Consensus-based recommendations for the management of juvenile localised scleroderma 179
Synovial hemangioma of infrapatellar (Hoffa) fat pad: Magnetic resonance imaging and ultrasound features 174
CXCR3/CXCL10 expression in the synovium of children with juvenile idiopathic arthritis 166
Anti-DFS70 antibodies in healthy schoolchildren: A follow-up analysis 166
Reduced levels of circulating progenitor cells in juvenile idiopathic arthritis are counteracted by anti TNF-α therapy. 161
Musculoskeletal pain in schoolchildren across puberty: A 3-year follow-up study 152
Life-threatening systemic capillary leak syndrome in juvenile dermatomyositis 147
A long-term follow-up study of methotrexate in juvenile localized scleroderma (morphea) 143
Abatacept for severe anti-tumor necrosis factor α refractory juvenile idiopathic arthritis-related uveitis 142
Severe clinical course of systemic lupus erythematosus in the first year of life 140
Longterm safety and efficacy of adalimumab and infliximab for uveitis associated with juvenile idiopathic arthritis 140
Congenital localized scleroderma 137
THU0532 RITUXIMAB FOR RAPIDLY PROGRESSIVE JUVENILE SYSTEMIC SCLEROSIS 136
Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: Results from a phase 3, randomised, double-blind withdrawal trial 134
Long-term outcome and prognostic factors of juvenile dermatomyositis: A multinational, multicenter study of 490 patients 134
CXCR6-CXCL16 interaction in the pathogenesis of Juvenile Idiopathic Arthritis. 130
Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trial. 130
Update of EULAR recommendations for the treatment of systemic sclerosis 130
Disease course and long-term outcome of juvenile localized scleroderma: Experience from a single pediatric rheumatology Centre and literature review 130
Sarcopenia in juvenile localized scleroderma: new insights on deep involvement 129
Monoarticular juvenile chronic arthritis of the shoulder: Report of a case and review of the literature 129
Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: A randomised trial 126
Prevalence of antinuclear antibodies in schoolchildren during puberty and possible relationship with musculoskeletal pain: A longitudinal study 126
Localized scleroderma of the face 126
Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study 125
Loss of efficacy during long-term infliximab therapy for sight-threatening childhood uveitis 125
Reliability of LoSCAT score for activity and tissue damage assessment in a large cohort of patients with Juvenile Localized Scleroderma 125
Consensus-based recommendations for the management of juvenile systemic sclerosis 125
A diagnostic score for molecular analysis of hereditary autoinflammatory syndromes with periodic fever in children 123
A computerized method to assess the skin involvement in localized scleroderma. 121
A preliminary disease severity score for juvenile systemic sclerosis 121
Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases - a multicentre prospective study 119
Recent advances in the management of juvenile systemic sclerosis 119
Clinical features and outcome of cogan syndrome 119
Triamcinolone acetonide and hexacetonide intra-articular treatment of symmetrical joints in juvenile idiopathic arthritis: a double-blind trial 117
Comparison of intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligoarticular juvenile idiopathic arthritis 117
Comparable efficacy of abatacept used as first-line or second-line biological agent for severe juvenile idiopathic arthritis-related uveitis 116
Case Report: Life-Threatening Macrophage Activation Syndrome With Fulminant Myocarditis Successfully Rescued by High Dose Intravenous Anakinra 115
Photopheresis in paediatric patients with drug-resistant chronic graft-versus-host disease. 113
The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients 113
Bone involvement as presenting sign of pediatric-onset Gaucher disease 113
Distinctive clinical features of pediatric systemic lupus erythematosus in three different age classes 110
Early predictors at severe course of uveitis in oligoarticular Juvenile idiopathic arthritis 110
Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry 109
Bone marrow edema in children: chronic nonbacterial osteomyelitis and its mimickers 107
CXCL10/CXCR3 interaction mediate chemotaxis of T cell into the synovium of children with oligoarticular juvenile idiopathic arthritis. 107
The European network for care of children with paediatric rheumatic diseases: care across borders 107
Subset-specific effects of sex hormones and pituitary gonadotropins on human lymphocyte proliferation in vitro 107
Immunopathogenesis of pediatric localized scleroderma 105
The pediatric rheumatology European Society American College of Rheumatology European league against rheumatism provisional classification criteria for juvenile systemic sclerosis 104
Follow-up and quality of life of patients with cryopyrin-associated periodic syndromes treated with Anakinra 104
Joint hypermobility and oligoarticular juvenile idiopathic arthritis: What relationship? 104
Successful treatment of gangrene in systemic necrotizing vasculitis with iloprost 104
CXCL10/CXCR3 interaction mediate chemotaxis of T cell into the synovium of children with oligoarticular juvenile idiopathic arthritis. 104
Otolaryngological manifestations of rheumatic diseases in children. 103
Osteoperiostitis in children: proposal for a diagnostic algorithm 103
Relapses of juvenile idiopathic arthritis in adulthood: A monocentric experience 102
Case of the month: A five-year-old girl with intractable arthralgias 102
Infrared thermography in children: A reliable tool for differential diagnosis of peripheral microvascular dysfunction and Raynaud's phenomenon? 102
Growth during tocilizumab therapy for polyarticular-course juvenile idiopathic arthritis: 2-year data from a phase III clinical trial 101
Juvenile idiopathic arthritis: Current and future treatment options 101
Acquired strabismus in linear scleroderma of the face 101
Performance of the preliminary definition of improvement in juvenile chronic arthritis patients treated with methotrexate 100
Treatment in Juvenile Scleroderma 100
Cone beam computed tomography for the assessment of linear scleroderma of the face 99
Psychological profile in children and adolescents with severe course Juvenile idiopathic arthritis 98
A child with dermatomyositis and a suspicious lymphadenopathy. 97
Clinical impact of MEFV mutations in children with periodic fever in a prevalent western European Caucasian population 97
Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis 97
Systemic sclerosis in childhood: Clinical and immunologic features of 153 patients in an international database 97
Juvenile and young adult-onset systemic sclerosis share the same organ involvement in adulthood: Data from the Eustar database 96
Systemic Sclerosis and Localized Scleroderma in Childhood 96
New Insights on Juvenile Psoriatic Arthritis 95
Prolactin receptor levels on lymphocytes vary with menstrual cycle in women 95
New developments in localized scleroderma 95
Methotrexate: New uses for an old drug 95
Scleroderma in children 95
Natural history and extracutaneous involvement of congenital morphea: Multicenter retrospective cohort study and literature review 94
Methotrexate in Linear Scleroderma: long-term efficacy in 50 children from a single Pediatric Rheumatology Centre 94
Immunopathogenesis of juvenile systemic sclerosis 94
The 1982 ARA/ACR criteria for theclassification of systemic lupus erythematosus in pediatric and adult patients 93
Joint hypermobility, growing pain and obesity are mutually exclusive as causes of musculoskeletal pain in schoolchildren 93
Scleroderma in children: An update 93
Temporomandibular Joint Involvement in Association With Quality of Life, Disability, and High Disease Activity in Juvenile Idiopathic Arthritis 93
Mycophenolate mofetil for methotrexate-resistant juvenile localized scleroderma 93
Reflex sympathetic dystrophy in children 92
Juvenile diabetes and systemic sclerosis: just a coincidence? 91
Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: An international collaboration 91
Evolution of echocardiographic and cardiac magnetic resonance imaging abnormalities during follow-up in patients with multisystem inflammatory syndrome in children 90
Outcome measures and medical progress: why outcome measures are needed in childhood arthritis 90
Periodic fevers with aphthous stomatitis, pharyngitis, and adenitis (PFAPA) 90
Is there a role for arthroscopic synovectomy in oligoarticular juvenile idiopathic arthritis? 89
The schedule of administration of canakinumab in cryopyrin associated periodic syndrome is driven by the phenotype severity rather than the age 89
Localized scleroderma 88
The interferon-gamma pathway is selectively up-regulated in the liver of patients with secondary hemophagocytic lymphohistiocytosis 88
Early echocardiographic and cardiac mri findings in multisystem inflammatory syndrome in children 88
Is Intraarticular Corticosteroid Injection (IAC) an effective therapy for Temporomandibular Joint (TMJ) Involvement in JIA? 85
Totale 11.547
Categoria #
all - tutte 51.309
article - articoli 48.450
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 342
Totale 100.101


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.277 0 0 0 137 157 51 29 183 252 130 225 113
2021/20221.638 56 192 176 129 90 60 83 166 191 36 122 337
2022/2023800 231 44 22 50 122 110 9 52 96 14 41 9
2023/2024567 21 75 69 36 57 33 52 24 27 9 76 88
2024/20253.149 25 189 82 90 435 129 180 240 308 113 575 783
2025/20265.266 499 1.152 1.947 1.668 0 0 0 0 0 0 0 0
Totale 15.647